THE EFFECT OF CIPROHEPTADINE ON SOME RISK FACTORS FOR COMORBID DISEASES

dc.contributor.author	Ibadova M.U
dc.contributor.author	Chernysh P.P
dc.date.accessioned	2025-12-31T13:03:56Z
dc.date.issued	2024-12-29
dc.description.abstract	The article analyzes the results of a study of the effect of cortisol on some hemodynamic and carbohydrate metabolism indices. A group of patients suffering from metabolic syndrome identified according to the IDF criteria (2005) was observed. At the time of the study, the patients were aged 40–59 years (mean age 54 years). Cyproheptadine was prescribed to reduce cortisol levels. The observation lasted 14 days. It was shown that against the background of cyproheptadine use, there is a decrease in the level of endogenous cortisol, blood pressure, glycemia, and immunoreactive insulin
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbml/article/view/4844
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/46238
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbml/article/view/4844/4099
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Management and Law; Vol. 41 (2024): WBML; 17-20
dc.source	2749-3601
dc.subject	blood pressure
dc.subject	hyperglycemia
dc.subject	cortisol
dc.subject	insulin
dc.title	THE EFFECT OF CIPROHEPTADINE ON SOME RISK FACTORS FOR COMORBID DISEASES
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: mu_2024_the_effect_of_ciproheptadine_on_some_ris.pdf
item.page.filesection.size: 326.63 KB
item.page.filesection.format: Adobe Portable Document Format